Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance

被引:55
作者
Doronzo, G
Russo, I
Mattiello, L
Anfossi, G
Bosia, A
Trovati, M [1 ]
机构
[1] Univ Turin, San Luigi Gonzaga, Dept Clin & Biol Sci, Diabet Unit, I-10043 Turin, Italy
[2] Univ Turin, Dept Genet Biol & Med Chem, I-10043 Turin, Italy
关键词
insulin resistance; insulin; nitric oxide; vascular endothelial growth factor; vascular smooth muscle cells;
D O I
10.1111/j.1365-2362.2004.01412.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background We aimed to evaluate whether insulin influences vascular endothelial growth factor (VEGF) synthesis and secretion in cultured vascular smooth muscle cells (VSMCs) via nitric oxide (NO) and whether these putative effects are lost in insulin-resistant states. Materials and methods In VSMC derived from human arterioles and from aortas of insulin-sensitive Zucker fa/+rats and insulin-resistant Zucker fa/fa rats incubated with different concentrations of human regular insulin with or without inhibitors of phosphatidylinositol 4,5-bisphosphate 3-kinase (PI3-K), mitogen-activated protein kinase (MAPK), nitric oxide synthase (NOS) and guanosine 3',5'cyclic monophosphate(cGMP)-dependent protein kinase (PKG), we measured protein expression (Western blot) and secretion (ELISA) of VEGF. Results We found that in VSMCs from humans and from insulin-sensitive Zucker fa/+rats, insulin increases VEGF protein expression and secretion, with mechanisms blunted by wortmannin and LY294002 (PI3-K inhibitors), PD98059 (MAPK inhibitor), L-NMMA (NOS inhibitor) and Rp-8pCT-cGMPs (PKG inhibitor). Also the NO donor sodium nitroprusside (SNP) and the cGMP analogue 8-Bromo-cGMP increase VEGF protein expression and secretion, with mechanisms inhibited by wortmannin and PD98059. The insulin effects on VEGF are impaired in VSMCs from Zucker fa/fa rats, which also present a reduced insulin ability to increase NO. Conclusions In VSMCs from humans and insulin-sensitive Zucker fa/+rats: (i) insulin increases VEGF protein expression and secretion via both PI3-K and MAPK; (ii) the insulin effects on VEGF are mediated by nitric oxide. The insulin action on both nitric oxide and VEGF is impaired in VSMCs from Zucker fa/fa rats, an animal model of metabolic and vascular insulin-resistance.
引用
收藏
页码:664 / 673
页数:10
相关论文
共 39 条
[1]   Effect of diabetes mellitus on formation of coronary collateral vessels [J].
Abaci, A ;
Oguzhan, A ;
Kahraman, S ;
Eryol, NK ;
Ünal, S ;
Arinç, H ;
Ergin, A .
CIRCULATION, 1999, 99 (17) :2239-2242
[2]   Nitric oxide is proangiogenic in the retina and choroid [J].
Ando, A ;
Yang, A ;
Mori, K ;
Yamada, H ;
Yamada, E ;
Takahashi, K ;
Saikia, J ;
Kim, M ;
Melia, M ;
Fishman, M ;
Huang, P ;
Campochiaro, PA .
JOURNAL OF CELLULAR PHYSIOLOGY, 2002, 191 (01) :116-124
[3]   Insulin influences the nitric oxide cyclic nucleotide pathway in cultured human smooth muscle cells from corpus cavernosum by rapidly activating a constitutive nitric oxide synthase [J].
Anfossi, G ;
Massucco, P ;
Mattiello, L ;
Balbo, A ;
Russo, I ;
Doronzo, G ;
Rolle, L ;
Ghigo, D ;
Fontana, D ;
Bosia, A ;
Trovati, M .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 147 (05) :689-700
[4]   Regulation of mitogen-activated protein kinase phosphatase-1 induction by insulin in vascular smooth muscle cells - Evaluation of the role of the nitric oxide signaling pathway and potential defects in hypertension [J].
Begum, N ;
Ragolia, L ;
Rienzie, J ;
McCarthy, M ;
Duddy, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (39) :25164-25170
[5]   Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells [J].
Bergandi, L ;
Silvagno, F ;
Russo, I ;
Riganti, C ;
Anfossi, G ;
Aldieri, E ;
Ghigo, D ;
Trovati, M ;
Bosia, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (12) :2215-2221
[6]   Insulin up-regulates vascular endothelial growth factor and stabilizes its messengers in endometrial adenocarcinoma cells [J].
Bermont, L ;
Lamielle, F ;
Lorchel, F ;
Fauconnet, S ;
Esumi, H ;
Weisz, A ;
Adessi, GL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01) :363-368
[7]   Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states - A possible explanation for impaired collateral formation in cardiac tissue [J].
Chou, E ;
Suzuma, I ;
Way, KJ ;
Opland, D ;
Clermont, AC ;
Naruse, K ;
Suzuma, K ;
Bowling, NL ;
Vlahos, CJ ;
Aiello, LP ;
King, GL .
CIRCULATION, 2002, 105 (03) :373-379
[8]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[9]   Guanylate cyclase and the .NO/cGMP signaling pathway [J].
Denninger, JW ;
Marletta, MA .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1999, 1411 (2-3) :334-350
[10]   Regulation of vascular endothelial growth factor synthesis by nitric oxide:: Facts and controversies [J].
Dulak, J ;
Józkowicz, A .
ANTIOXIDANTS & REDOX SIGNALING, 2003, 5 (01) :123-132